期刊文献+

社区强化管理对2型糖尿病患者的管理效果分析 被引量:4

原文传递
导出
摘要 目的对社区强化管理对2型糖尿病患者的管理效果进行分析判定。方法 2型糖尿病患者60例随机分组为A组及B组,A组给予普通治疗,B组在普通治疗的基础上进行社区强化管理干预,并观察2组血糖、糖化血红蛋白及血脂水平及治疗依从性。结果 B组患者的空腹血糖(FBG)、餐后2 h血糖(2h PG)、糖化血红蛋白(Hb Alc)、胆固醇(TG)、低密度脂蛋白(LDL-C)、治疗依从性均优于A组(P<0.05)。结论社区强化管理干预效果显著,值得推广。
出处 《中国地方病防治》 北大核心 2017年第5期513-513,516,共2页 Chinese Journal of Control of Endemic Diseases
  • 相关文献

参考文献3

二级参考文献28

  • 1International Diabetes Federation. KEY FINGDINGS 2014 [ C ]. http ://www. idf. org/diabetesatlas/update-2014.
  • 2Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[ J]. JAMA, 2013,310(9) :948-959. DOI: 10. 1001/ jama. 2013. 168118.
  • 3Gaede P, Lund-Andersen H, Parving HH, et al. Effect of a multifac- torial intervention on mortality in type 2 diabetes [ J ]. N Engl J Med, 2008,358 (6) :580-591. DOI : 10. 1056/NEJMoa0706245.
  • 4Garber AJ, Abrahamson MJ, Barzilay JI, et al. Aace/Ace comprehe- nsive diabetes management algorithm 2015 [ J ]. Endocr Pract, 2015,21 (4) :438-447. DOI: 10. 4158/EP15693.
  • 5CS. American Diabetes Association. Standards of Medical Care in Diabetes- 2015[J]. Diabetes Care, 2015,38(Suppl) :S1-$2. doi: 10. 2337/ dcl5-SO01.
  • 6Ward WK, Bolgiano DC, McKnight B, et al. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus[J]. J Clin Invest, 1984,74(4) :1318-1328. doi: 10. 1172/ JCI111542.
  • 7Dunning BE, Foley JE, Ahr~n B. Alpha cell function in health and disease : influence of glueagon-like peptide-1 [ J]. Diabetologia, 2005, 48 (9) : 1700-1713. DO! 10. 1007/s00125-005-1878-0.
  • 8Torrens JI, Skurniek J, Davidow AL, et al. Ethnic differences in insulin sensitivity and beta-cell function in premenopansal or early perimenopausal women without diabetes: the Study of Women's Health across the Nation ( SWAN ) [ J ]. Diabetes Care, 2004,27 ( 2 ) : 354- 361. doi:10. 2337/diacare. 27.2. 354.
  • 9Migoya EM, Bergemn R, Miller JL, et al. Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1 [ J ]. Clin Pharmacol Yher, 2010, 88 (6): 801-808. doi: 10. 1038/clpt. 2010. 184.
  • 10Bailey C J, Asehner P, Del Prato S, et al. Individualized glycaemic targets and pharmaeotherapy in type 2 diabetes [ J ]. Diab Yasc Dis Res, 2013,10 ( 5 ) : 397-409. doi : 10.1177/1479164113490765.

共引文献30

同被引文献55

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部